Carboplatin plus oral etoposide in the management of unresectable non-small cell lung cancer. Preliminary results of a Vanderbilt trial.

Johnson DH, Hainsworth JD, DeVore R, Hande KR, Greco FA
Oncology. 1992 49 Suppl 1: 57-61; discussion 61-2

PMID: 1323813 · DOI:10.1159/000227112

MeSH Terms (13)

Administration, Oral Antineoplastic Combined Chemotherapy Protocols Carboplatin Carcinoma, Non-Small-Cell Lung Etoposide Female Humans Leukocyte Count Lung Neoplasms Male Middle Aged Neoplasm Staging Platelet Count

Connections (1)

This publication is referenced by other Labnodes entities: